Hypercoagulability of COVID-19 and Neurological Complications: A Review.

J Stroke Cerebrovasc Dis

Loyola University Medical Center Department of Internal Medicine Division of Hematology and Oncology and Department of Cancer Biology, Loyola University Chicago Assistant Professor of Medicine, United States. Electronic address:

Published: January 2022

The SARS-CoV-2 virus, which causes Coronavirus disease 2019 (COVID-19), has resulted in millions of worldwide deaths. When the SARS-CoV-2 virus emerged from Wuhan, China in December 2019, reports of patients with COVID-19 revealed that hospitalized patients had acute changes in mental status, cognition, and encephalopathy. Neurologic complications can be a consequence from overall severity of the systemic infection, direct viral invasion of the SARS-CoV-2 virus in the central nervous system, and possible immune mediated mechanisms. We will examine the landscape regarding this topic in this review in addition to current understandings of COVID-19 and hemostasis, treatment, and prevention, as well as vaccination.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547944PMC
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.106163DOI Listing

Publication Analysis

Top Keywords

sars-cov-2 virus
12
hypercoagulability covid-19
4
covid-19 neurological
4
neurological complications
4
complications review
4
review sars-cov-2
4
virus coronavirus
4
coronavirus disease
4
disease 2019
4
2019 covid-19
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!